Rojek Amanda, Horby Peter, Dunning Jake
Epidemic Diseases Research Group Oxford (ERGO), Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Epidemic Diseases Research Group Oxford (ERGO), Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Lancet Infect Dis. 2017 Sep;17(9):e280-e292. doi: 10.1016/S1473-3099(17)30234-7. Epub 2017 Apr 28.
The west Africa Ebola virus disease (EVD) epidemic was extraordinary in scale. Now that the epidemic has ended, it is a relevant time to examine published studies with direct relevance to clinical care and, more broadly, to examine the implications of the clinical research response mounted. Clinically relevant research includes literature detailing risk factors for and clinical manifestations of EVD, laboratory and other investigation findings in patients, experimental vaccine and therapeutic clinical trials, and analyses of survivor syndrome. In this Review, we discuss new insights from patient-oriented research completed during the west Africa epidemic, identify ongoing knowledge gaps, and suggest priorities for future research.
西非埃博拉病毒病(EVD)疫情规模巨大。鉴于疫情已经结束,现在是审视与临床护理直接相关的已发表研究的适当时机,更广泛地说,是审视所采取的临床研究应对措施的影响。临床相关研究包括详细阐述埃博拉病毒病风险因素和临床表现的文献、患者的实验室及其他检查结果、实验性疫苗和治疗性临床试验,以及对幸存者综合征的分析。在本综述中,我们讨论了西非疫情期间完成的以患者为导向的研究所取得的新见解,确定了当前存在的知识空白,并提出了未来研究的重点。